{'fraction_non_alphanumeric': 0.03455723542116631, 'fraction_numerical': 0.014038876889848811, 'mean_word_length': 5.3493150684931505, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Transfusion-Associated Graft-versus-Host Disease in Patients with and without Immunodeficiency: Report of Six Cases

Transfusion-associated graft-versus-host disease (TA-GVHD) is extremely rare compared to transplant- associated GVHD. Mortality in TA-GVHD approaches to 100%. We report six cases with TA-GVHD that were seen during 1994-2004 and discuss the clinical characteristics. Case Reports: Two patients were immunosuppressed, and 4 patients were immunocompetent. All 6 patients were transfused with non-irradiated blood products from relatives before TA-GVHD had occurred. Diagnosis of TA-GVHD in all patients was made based on characteristic clinical manifestations and laboratory findings. All patients died due to TA-GVHD-related complications such as progressive pancytopenia and liver dysfunctions. Conclusion: Our data shows that TA-GVHD is a serious complication of transfusion of blood products among relatives.